Published in

Wiley, Hematological Oncology, 5(40), p. 1100-1104, 2022

DOI: 10.1002/hon.3032

Links

Tools

Export citation

Search in Google Scholar

Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia

Journal article published in 2022 by Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci ORCID, Riccardo Moia ORCID, Clara Deambrogi, Silvia Rasi, Francesco Autore ORCID, Michele Merli ORCID, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo’, Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO